Top

Published in:

01-01-2019 | Review

Diagnostic/classification criteria in pediatric Behçet’s disease

Author: Ezgi Deniz Batu

Published in: Rheumatology International | Issue 1/2019

Abstract

Behçet’s disease (BD) is a variable vessel vasculitis characterized by recurrent oral and genital aphthosis accompanied by skin, ocular, gastrointestinal, neurologic, and articular involvement. BD is not common in childhood and the disease characteristics considerably differ between adults and children. 18 diagnostic/classification criteria have been published for BD to date. The pediatric BD (PEDBD) criteria, published in 2015, focused on pediatric BD, while the others mainly based on adult studies and are not validated for children. The aim of this review is to summarize the data about diagnostic/classification criteria for BD and to discuss the use and performance of the current criteria in pediatric BD. The covered topics are the characteristics of the diagnostic/classification criteria sets for BD, the factors restricting the universal use/acceptance of these criteria, and pediatric studies testing the performance of BD criteria sets. Having valid and universally accepted criteria with high performance is very important in pediatric BD as they help us determine patients for our studies and guide us through our clinical practice. There are less than 10 pediatric studies testing the performances of BD diagnostic/classification criteria. Their results suggest that revised ICBD (The International Criteria for BD) has the highest sensitivity, while ISG (The International Study Group) criteria remain as the most specific criteria set. Larger multinational pediatric BD cohorts with adequate control groups are required to compare the performance of the different criteria sets in children and to improve the performance of the existing PEDBD criteria.

Batu ED, Ozen S (2012) Pediatric vasculitis. Curr Rheumatol Rep 14(2):121–129. https://doi.org/10.1007/s11926-011-0232-4 CrossRefPubMed

Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65(1):1–11. https://doi.org/10.1002/art.37715 CrossRefPubMed

Kone-Paut I (2016) Behcet’s disease in children, an overview. Pediatr Rheumatol 14(1):10. https://doi.org/10.1186/s12969-016-0070-z CrossRef

Davatchi F, Chams-Davatchi C, Shams H, Shahram F, Nadji A, Akhlaghi M, Faezi T, Ghodsi Z, Sadeghi Abdollahi B, Ashofteh F, Mohtasham N, Kavosi H, Masoumi M (2017) Behcet’s disease: epidemiology, clinical manifestations, and diagnosis. Expert Rev Clin Immunol 13(1):57–65. https://doi.org/10.1080/1744666X.2016.1205486 CrossRefPubMed

Atmaca L, Boyvat A, Yalcindag FN, Atmaca-Sonmez P, Gurler A (2011) Behcet disease in children. Ocul Immunol Inflamm 19(2):103–107. https://doi.org/10.3109/09273948.2011.555592 CrossRefPubMed

Ishido T, Horita N, Takeuchi M, Kawagoe T, Shibuya E, Yamane T, Hayashi T, Meguro A, Ishido M, Minegishi K, Yoshimi R, Kirino Y, Kato S, Arimoto J, Ishigatsubo Y, Takeno M, Kurosawa M, Kaneko T, Mizuki N (2017) Clinical manifestations of Behcet’s disease depending on sex and age: results from Japanese nationwide registration. Rheumatology 56(11):1918–1927. https://doi.org/10.1093/rheumatology/kex285 CrossRefPubMed

Shahram F, Nadji A, Akhlaghi M, Faezi ST, Chams-Davatchi C, Shams H, Ghodsi SZ, Davatchi F (2018) Paediatric Behcet’s disease in Iran: report of 204 cases. Clin Exp Rheumatol 36

Koné-Paut IBJ (1993) La maladie de Behçet chez l’enfant en France. Arch Fr Pediatr 50:561–563PubMed

Borlu M, Uksal U, Ferahbas A, Evereklioglu C (2006) Clinical features of Behcet’s disease in children. Int J Dermatol 45(6):713–716. https://doi.org/10.1111/j.1365-4632.2006.02754.x CrossRefPubMed

10.

Nanthapisal S, Klein NJ, Ambrose N, Eleftheriou D, Brogan PA (2016) Paediatric Behcet’s disease: a UK tertiary centre experience. Clin Rheumatol 35(10):2509–2516. https://doi.org/10.1007/s10067-016-3187-z CrossRefPubMedPubMedCentral

11.

Kone-Paut I, Shahram F, Darce-Bello M, Cantarini L, Cimaz R, Gattorno M, Anton J, Hofer M, Chkirate B, Bouayed K, Tugal-Tutkun I, Kuemmerle-Deschner J, Agostini H, Federici S, Arnoux A, Piedvache C, Ozen S, Group P (2015) Consensus classification criteria for paediatric Behcet’s disease from a prospective observational cohort: PEDBD. Ann Rheum Dis 75(6):958–964. https://doi.org/10.1136/annrheumdis-2015-208491 CrossRefPubMed

12.

Karincaoglu Y, Borlu M, Toker SC, Akman A, Onder M, Gunasti S, Usta A, Kandi B, Durusoy C, Seyhan M, Utas S, Saricaoglu H, Ozden MG, Uzun S, Tursen U, Cicek D, Donmez L, Alpsoy E (2008) Demographic and clinical properties of juvenile-onset Behcet’s disease: a controlled multicenter study. J Am Acad Dermatol 58(4):579–584. https://doi.org/10.1016/j.jaad.2007.10.452 CrossRefPubMed

13.

Kitaichi N, Ohno S (2008) Behcet disease in children. Int Ophthalmol Clin 48(3):87–91. https://doi.org/10.1097/IIO.0b013e31817d8393 CrossRefPubMed

14.

Davatchi F (2014) Behcet’s disease. Int J Rheum Dis 17(4):355–357. https://doi.org/10.1111/1756-185X.12378 CrossRefPubMed

15.

Saadoun D, Wechsler B (2012) Behcet’s disease. Orphanet J Rare Dis 7:20. https://doi.org/10.1186/1750-1172-7-20 CrossRefPubMedPubMedCentral

16.

Chang HK, Kim SY (2003) Survey and validation of the criteria for Behcet’s disease recently used in Korea: a suggestion for modification of the International Study Group criteria. J Korean Med Sci 18(1):88–92. https://doi.org/10.3346/jkms.2003.18.1.88 CrossRefPubMedPubMedCentral

17.

Chang HK, Lee SS, Bai HJ, Lee YW, Yoon BY, Lee CH, Lee YH, Song GG, Chung WT, Lee SW, Choe JY, Kim CG, Chang DK (2004) Validation of the classification criteria commonly used in Korea and a modified set of preliminary criteria for Behcet’s disease: a multi-center study. Clin Exp Rheumatol 22(4 Suppl 34):S21–S26PubMed

18.

Hewitt J, Escande JP, Lauret P, Perlemuter L (1969) Criteria for diagnosis of Behcet’s syndrome. Bull Soc Fr Dermatol Syphiligr 76(4):565–568PubMed

19.

Hewitt J, Escande JP, Manesse S (1971) Revision of the diagnostic criteria of Behcet’s syndrome. Presse Med 79(20):901PubMed

20.

Mason RM, Barnes CG (1969) Behcet’s syndrome with arthritis. Ann Rheum Dis 28(2):95–103CrossRef

21.

Mizushima Y (1988) Recent research into Behcet’s disease in Japan. Int J Tissue React 10(2):59–65PubMed

22.

International Team for the Revision of the International Criteria for Behcet’s D (2014) The International Criteria for Behcet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J EurAcad Dermatol Venereol 28(3):338–347. https://doi.org/10.1111/jdv.12107 CrossRef

23.

International Study Group for Behcet’s Disease (1990) Criteria for diagnosis of Behcet’s disease. Lancet 335(8697):1078–1080

24.

The International Study Group for Behcet’s disease (1992) Evaluation of diagnostic (‘classification’) criteria in Behcet’s disease–towards internationally agreed criteria. Br J Rheumatol 31(5):299–308CrossRef

25.

Curth HO (1946) Recurrent genito-oral aphthosis with hypopion (Behcet’s syndrome). Arch Dermatol 54:179–196

26.

Behcet’s Disease Research Committee of Japan (1974) Behcet’s disease guide to the diagnosis of Behcet’s disease. Japan J Ophthalmol 18:291–294

27.

Hubault A, Hamza M (1974) La maladie de Behçet en 1974. In: de Seze S et al (eds) L’actualite rhumatologique, vol 15. Expension Scientifique, Paris, pp 43–55

28.

O’Duffy JD (1974) Critères proposés pour le diagnostique de la maladie de Behçet et notes therapeutiques. Rev Med (Paris) 36:2371–2379

29.

Cheng SP, Zhang X-Q (1980) Some special clinical manifestations of Behçet’s disease-report of illustrative cases and review of the literature (author’s transl). Chinese J Intern Med 19:15–22

30.

Dilsen N, Konice M, Aral O (1986) Our diagnostic criteria of Behcet’s disease-an overview. In: Lehner T, Barnes CG (eds) Recent advances in Behçet’s disease, vol International Congress and Symposium Series 103. London Royal Society of Medicine Services, London, pp 177–180

31.

Davatchi F, Shahram F, Akbarian M et al (1993) Accuracy of existing diagnostic criteria for Behçet’s disease. In: Wechsler B, Godeau P (eds) Behcet’s disease. Excerpta Medica International Congress Series 1037, Amsterdam, pp 225–228

32.

International Team for the Revision of the International Criteria for Behçet’s disease (2006) Revision of the International Criteria for Behçet’s disease (ICBD). Clin Exp Rheumatol 24(Suppl. 42):S14–S15

33.

Dilsen N (2000) About diagnostic criteria for Behcet’s Disease: our new proposal. In: Bang D, Lee ES, Lee S (eds) Behçet’s Disease. Design Mecca Publishing Co., Seoul, pp 101–104

34.

Davatchi F, Shahram F, Akbarian M et al (1993) Classification tree for the diagnosis of Behçet’s disease. In: Wechsler B, Godeau P (eds) Behçet’s Disease. Excerpta Medica International Congress Series 1037, Amsterdam, pp 245–248

35.

Davatchi F, Sadeghi Abdollahi B, Chams-Davatchi C, Shahram F, Shams H, Nadji A, Faezi T, Akhlaghi M, Ghodsi Z, Mohtasham N, Ashofteh F (2015) The saga of diagnostic/classification criteria in Behcet’s disease. Int J Rheum Dis 18(6):594–605. https://doi.org/10.1111/1756-185X.12520 CrossRefPubMed

36.

Davatchi F, Chams-Davatchi C, Shahram F, Nadji A, Shams H, Ghodsi Z, Akhlaghi M, Naderi N, Sadeghi-Abdolahi B (2007) Pathergy test in Behçet’s disease: change in incidence over the time. APLAR J Rheumatol 10:333–335CrossRef

37.

Batu ED, Ozen S (2015) Vasculitis: do we know more to classify better? Pediatr Nephrol 30(9):1425–1432. https://doi.org/10.1007/s00467-014-3015-0 CrossRefPubMed

38.

Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31(11):1409–1417. https://doi.org/10.1007/s00296-011-1999-3 CrossRefPubMed

39.

Treudler R, Orfanos CE, Zouboulis CC (1999) Twenty-eight cases of juvenile-onset Adamantiades-Behcet disease in Germany. Dermatology 199(1):15–19. https://doi.org/10.1159/000018197 CrossRefPubMed

40.

Kotter I, Vonthein R, Muller CA, Gunaydin I, Zierhut M, Stubiger N (2004) Behcet’s disease in patients of German and Turkish origin living in Germany: a comparative analysis. J Rheumatol 31(1):133–139PubMed

41.

Davatchi F, Chams-Davatchi C, Shams H, Nadji A, Faezi T, Akhlaghi M, Sadeghi Abdollahi B, Ashofteh F, Ghodsi Z, Mohtasham N, Shahram F (2016) Adult Behcet’s disease in Iran: analysis of 6075 patients. Int J Rheum Dis 19(1):95–103. https://doi.org/10.1111/1756-185X.12691 CrossRefPubMed

42.

Gallizzi R, Pidone C, Cantarini L, Finetti M, Cattalini M, Filocamo G, Insalaco A, Rigante D, Consolini R, Maggio MC, Civino A, Martino S, Olivieri AN, Fabio G, Pastore S, Mauro A, Sutera D, Trimarchi G, Ruperto N, Gattorno M, Cimaz R (2017) A national cohort study on pediatric Behcet’s disease: cross-sectional data from an Italian registry. Pediatr Rheumatol Online J 15(1):84. https://doi.org/10.1186/s12969-017-0213-x CrossRefPubMedPubMedCentral

43.

Kim DY, Choi MJ, Cho S, Kim DW, Bang D (2014) Changing clinical expression of Behcet disease in Korea during three decades (1983–2012): chronological analysis of 3674 hospital-based patients. Br J Dermatol 170(2):458–461. https://doi.org/10.1111/bjd.12661 CrossRefPubMed

44.

Kone-Paut I, Yurdakul S, Bahabri SA, Shafae N, Ozen S, Ozdogan H, Bernard JL (1998) Clinical features of Behcet’s disease in children: an international collaborative study of 86 cases. J Pediatr 132(4):721–725CrossRef

45.

Aeschlimann FA, Batu ED, Canna SW, Go E, Gul A, Hoffmann P, Leavis HL, Ozen S, Schwartz DM, Stone DL, van Royen-Kerkof A, Kastner DL, Aksentijevich I, Laxer RM (2018) A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease. Ann Rheum Dis 77(5):728–735. https://doi.org/10.1136/annrheumdis-2017-212403 CrossRefPubMed

46.

Ozen S, Batu ED (2018) Vasculitis Pathogenesis: can we talk about precision medicine? Front Immunol 9:1892. https://doi.org/10.3389/fimmu.2018.01892 CrossRefPubMedPubMedCentral

47.

Alpsoy E, Elpek GO, Yilmaz F, Ciftcioglu MA, Akman A, Uzun S, Karakuzu A (2005) Androgen receptor levels of oral and genital ulcers and skin pathergy test in patients with Behcet’s disease. Dermatology 210(1):31–35. https://doi.org/10.1159/000081480 CrossRefPubMed

48.

Bonitsis NG, Luong Nguyen LB, LaValley MP, Papoutsis N, Altenburg A, Kotter I, Micheli C, Maldini C, Mahr A, Zouboulis CC (2015) Gender-specific differences in Adamantiades-Behcet’s disease manifestations: an analysis of the German registry and meta-analysis of data from the literature. Rheumatology 54(1):121–133. https://doi.org/10.1093/rheumatology/keu247 CrossRefPubMed

49.

Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, Yurdakul S, Yazici H (2003) The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine 82(1):60–76CrossRef

50.

Saadoun D, Wechsler B, Desseaux K, Le Thi Huong D, Amoura Z, Resche-Rigon M, Cacoub P (2010) Mortality in Behcet’s disease. Arthritis Rheum 62(9):2806–2812. https://doi.org/10.1002/art.27568 CrossRefPubMed

51.

Kim DK, Chang SN, Bang D, Lee ES, Lee S (1994) Clinical analysis of 40 cases of childhood-onset Behcet’s disease. Pediatr Dermatol 11(2):95–101CrossRef

52.

Kone-Paut I, Darce-Bello M, Shahram F, Gattorno M, Cimaz R, Ozen S, Cantarini L, Tugal-Tutktun I, Assaad-Khalil S, Hofer M, Kuemmerle-Deschner J, Benamour S, Al Mayouf S, Pajot C, Anton J, Faye A, Bono W, Nielsen S, Letierce A, Tran TA, Committee P-BIE (2011) Registries in rheumatological and musculoskeletal conditions. Paediatric Behcet’s disease: an international cohort study of 110 patients. One-year follow-up data. Rheumatology 50(1):184–188. https://doi.org/10.1093/rheumatology/keq324 CrossRefPubMed

53.

Krause I, Uziel Y, Guedj D, Mukamel M, Harel L, Molad Y, Weinberger A (1999) Childhood Behcet’s disease: clinical features and comparison with adult-onset disease. Rheumatology 38(5):457–462CrossRef

54.

Sibley C, Yazici Y, Tascilar K, Khan N, Bata Y, Yazici H, Goldbach-Mansky R, Hatemi G (2014) Behcet syndrome manifestations and activity in the United States versus Turkey—a cross-sectional cohort comparison. J Rheumatol 41(7):1379–1384. https://doi.org/10.3899/jrheum.131227 CrossRefPubMedPubMedCentral

55.

Kobayashi T, Kishimoto M, Swearingen CJ, Filopoulos MT, Ohara Y, Tokuda Y, Oshikawa H, Yoshida K, Utsunomiya M, Kimura M, Okada M, Matsui K, Yazici Y (2013) Differences in clinical manifestations, treatment, and concordance rates with two major sets of criteria for Behcet’s syndrome for patients in the US and Japan: data from a large, three-center cohort study. Mod Rheumatol 23(3):547–553. https://doi.org/10.1007/s10165-012-0696-8 CrossRefPubMed

56.

Moosmann T, Veraar C, Brunner J, Fraedrich G, Frech A, Horninger W, Ratzinger G, Streif W, Teuchner B, Willeit J, Zlamy M, De Zordo T, Schirmer M (2018) Differential clinical presentation of Adamantiades-Behcet’s disease in non-endemic and endemic areas: retrospective data from a Middle-European cohort study. Int J Rheum Dis. https://doi.org/10.1111/1756-185X.13306 CrossRefPubMedPubMedCentral

57.

Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M, Faezi T, Ghodsi Z, Faridar A, Ashofteh F, Sadeghi Abdollahi B (2010) Behcet’s disease: from East to West. Clin Rheumatol 29(8):823–833. https://doi.org/10.1007/s10067-010-1430-6 CrossRefPubMed

58.

Batu ED, Sonmez HE, Sozeri B, Butbul Aviel Y, Bilginer Y, Ozen S (2017) The performance of different classification criteria in paediatric Behcet’s disease. Clin Exp Rheumatol 35(6):119–123PubMed

59.

Assar S, Sadeghi B, Davatchi F, Ghodsi SZ, Nadji A, Shahram F, Ashofte F, Larimi SR, Sadeghi M (2017) The association of pathergy reaction and active clinical presentations of Behcet’s disease. Reumatologia 55(2):79–83. https://doi.org/10.5114/reum.2017.67602 CrossRefPubMedPubMedCentral

60.

Davatchi F, Sadeghi Abdollahi B, Chams-Davatchi C, Shahram F, Ghodsi Z, Nadji A, Akhlaghi M, Faezi T, Shams H, Larimi R, Ashofteh F (2013) Impact of the positive pathergy test on the performance of classification/diagnosis criteria for Behcet’s disease. Mod Rheumatol 23(1):125–132. https://doi.org/10.1007/s10165-012-0626-9 CrossRefPubMed

61.

Faezi ST, Paragomi P, Shahram F, Shams H, Shams-Davatchi C, Ghodsi Z, Nadji A, Akhlaghi M, Davatchi F (2014) Clinical features of Behcet’s disease in patients without oral aphthosis. Mod Rheumatol 24(4):637–639. https://doi.org/10.3109/14397595.2013.844400 CrossRefPubMed

62.

Mat MC, Goksugur N, Engin B, Yurdakul S, Yazici H (2006) The frequency of scarring after genital ulcers in Behcet’s syndrome: a prospective study. Int J Dermatology 45(5):554–556. https://doi.org/10.1111/j.1365-4632.2006.02859.x CrossRef

Title: Diagnostic/classification criteria in pediatric Behçet’s disease
Author: Ezgi Deniz Batu
Publication date: 01-01-2019
Publisher: Springer Berlin Heidelberg
Published in: Rheumatology International / Issue 1/2019
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-018-4208-9

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Diagnostic/classification criteria in pediatric Behçet’s disease

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2019

Patient-reported outcomes with golimumab in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: non-interventional study GO-NICE in Germany

Is age associated with disease severity and compliance to treatment in children with familial Mediterranean fever?

Rheumatology in Egypt: back to the future

Efficacy and safety of biological therapy compared to synthetic immunomodulatory drugs or placebo in the treatment of Behçet’s disease associated uveitis: a systematic review

Familial Mediterranean fever and periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: shared features and main differences

Genetic variations in the IL-12B gene in association with IL-23 and IL-12p40 serum levels in ankylosing spondylitis

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page